QXO (QXO) had the highest return between December 21, 2023 and January 4, 2024 by a large-cap US stock, returning 79.8%.
| ASSET | DATE | % RETURN |
|---|---|---|
QXO (QXO) | 12/21/2023 - 1/4/2024 | 79.79% |
Moderna (MRNA) | 12/21/2023 - 1/4/2024 | 24.18% |
Rocket Lab USA (RKLB) | 12/21/2023 - 1/4/2024 | 21.83% |
argenx NV ADR (ARGX) | 12/21/2023 - 1/4/2024 | 16.31% |
IREN (IREN) | 12/21/2023 - 1/4/2024 | 15.21% |
Grupo Cibest (CIB) | 12/21/2023 - 1/4/2024 | 14.17% |
Trip Group Ltd ADR (TCOM) | 12/21/2023 - 1/4/2024 | 13.12% |
MicroStrategy (MSTR) | 12/21/2023 - 1/4/2024 | 11.51% |
Merck (MRK) | 12/21/2023 - 1/4/2024 | 10.61% |
Neurocrine Biosciences (NBIX) | 12/21/2023 - 1/4/2024 | 10.36% |
Viatris (VTRS) | 12/21/2023 - 1/4/2024 | 10% |
Amgen (AMGN) | 12/21/2023 - 1/4/2024 | 9.63% |
Allstate (ALL) | 12/21/2023 - 1/4/2024 | 9.43% |
Summit Therapeutics (SMMT) | 12/21/2023 - 1/4/2024 | 8.91% |
Incyte (INCY) | 12/21/2023 - 1/4/2024 | 8.9% |
Flex (FLEX) | 12/21/2023 - 1/4/2024 | 8.39% |
Regeneron Pharmaceuticals (REGN) | 12/21/2023 - 1/4/2024 | 8.14% |
Novartis AG ADR (NVS) | 12/21/2023 - 1/4/2024 | 7.91% |
Vaxcyte (PCVX) | 12/21/2023 - 1/4/2024 | 7.77% |
Eli Lilly and (LLY) | 12/21/2023 - 1/4/2024 | 7.54% |
Molina Healthcare (MOH) | 12/21/2023 - 1/4/2024 | 7.28% |
Gilead Sciences (GILD) | 12/21/2023 - 1/4/2024 | 7.18% |
Interactive Brokers (IBKR) | 12/21/2023 - 1/4/2024 | 6.99% |
Revolution Medicines (RVMD) | 12/21/2023 - 1/4/2024 | 6.94% |
Globalstar, Inc Common Stock (GSAT) | 12/21/2023 - 1/4/2024 | 6.7% |
Large-cap stocks are treated as having a market cap of $10B+.